Content
and Copyright
i
Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
-
Published Date:
Sep 2003
Publisher's site:Source:Emerg Infect Dis. 9(9):1168-1169.
[PDF-174.92 KB]
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.
-
Subject:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
image/gif 
image/jpeg 
text/plain
text/plain
No Related Documents.
You May Also Like:
-
Published Date:Source:File Type:[PDF - 336.07 KB]
File Type:[PDF - 336.07 KB]
Published Date:Source:Description:File Type:[PDF - 101.16 KB]
File Type:[PDF - 101.16 KB]
Published Date:Source:File Type:[PDF - 44.63 KB]
File Type:[PDF - 44.63 KB]
Published Date:Source:Description:File Type:[PDF - 46.55 KB]
File Type:[PDF - 46.55 KB]
Published Date:Source:Description:File Type:[PDF - 218.19 KB]
File Type:[PDF - 218.19 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
